ダウンロード数 : ?
ファイル
言語
英語
著者
石川 悟
Matsui, Yasunori
Wachi, Satoshi
Yamaguchi, Hiroshi
原嶋 奈々江
内容記述(抄録等)
Because cancer is associated with aging, immunological features in the aged should be considered in anticancer immunotherapy. In this study, we investigated antitumor immunity in aged mice using a CT26 colon carcinoma model. The tumor growth of CT26 was accelerated in aged mice compared with that in young mice, but this difference was not observed in nude mice. The serum levels of IL-6 and TNF-α were higher in aged mice than those in young mice, irrespective of the CT26-bearing state. The in vitro induction of CT26-specific CTLs from aged mice that were vaccinated with doxorubicin (DTX)-treated CT26 cells was impaired. In vivo neutralization of IL-6, but not TNF-α, showed a tendency to restore the in vitro induction of CT26-specific CTLs from vaccinated aged mice. Analyses on tumor-infiltrating immune cells as early as day 5 after CT26 inoculation revealed that monocytic and granulocytic MDSCs preferentially infiltrated into tumor sites in aged mice compared with young mice. Alternatively, oral administration of Lentinula edodes mycelia (L.E.M.) extract, which has the potential to suppress inflammation in tumor-bearing hosts, decreased the serum levels of IL-6 in aged mice. When administration of L.E.M. extract was started 1 week earlier, CT26 growth was retarded in aged mice and the in vivo priming of tumor-specific CTLs was improved in CT26-vaccinated aged mice. These results indicate early infiltration of MDSCs is related to impaired immunity of aged hosts and that oral administration of L.E.M. extract can mitigate the impairment.
主題
Aging
Inflammation
IL-6
MDSC
T cell immunity
掲載誌名
Cancer Immunology and Immunotherapy
65
8
開始ページ
961
終了ページ
972
ISSN
03407004
発行日
2016-08
DOI
DOI公開日
2017-03-15
PubMed ID
NCID
AA00598499
出版者
Springer
資料タイプ
学術雑誌論文
ファイル形式
PDF
権利関係
© Springer-Verlag Berlin Heidelberg 2016
著者版/出版社版
著者版
部局
医学部
このエントリーをはてなブックマークに追加